Azithromycin
Established medicineAlso known as AzaSite, Azitromicina, Zithromax, Zmax+2 more
AzaSite, Azitromicina, Zithromax, Zmax, Azithromycine, Azithromycinum.
Recent clinical, regulatory, research and industry developments relating to this drug.
Improving Cognition and Gestational Duration With Targeted Nutrition
Label change: AZITHROMYCIN (ANDA203294)
Real-World U.S. Data Back Azithromycin After Unscheduled C-Sections
Label change: AZITHROMYCIN (ANDA203294)
Label change: AZITHROMYCIN (ANDA203294)
Cardiovascular manifestations and treatment considerations in COVID-19.
Label change: AZITHROMYCIN (ANDA203294)
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Pharmacology & targets
Known molecular targets and mechanisms supported by curated pharmacology databases.
Regulatory timeline
The complete regulatory record, grouped by authority — approvals, safety advisories and label changes. Each authority shows its most recent events; expand one to read its full history.
Data from the U.S. Food and Drug Administration (U.S. Food and Drug Administration), public domain (CC0).
Clinical trials
The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.
Late-stage studies
Phase III+ trials still open or recently active — where late-stage evidence is being generated.
Recent completions
Trials that read out recently, adding to the completed evidence base.
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Major research themes5
Journals, researchers & institutions
- Aging1
- Archives of ophthalmology (Chicago, Ill. : 1960)1
- Heart (British Cardiac Society)1
- JAMA cardiology1
- Journal of the American Board of Family Medicine : JABFM1
- Alemayehu W1
- Chen T1
- Chen Y1
- Ferrari V1
- Gaydos C1
- Gold HS1
- Grasmick M1
- Hahn DL1
- Beth Israel Deaconess Medical Center1
- Dana Center for Preventive Ophthalmology1
- Dean Clinic1
- Harvard-Thorndike Electrophysiology Institute1
- School of Science1
- University of Pennsylvania Perelman School of Medicine1
Related diseases
Regulator-approved indications and conditions co-mentioned with this drug across the research literature. Number shows shared papers.
Related drugs
Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).
Studied across 10 of the same disease areas as Azithromycin in the shared literature.
Studied across 9 of the same disease areas as Azithromycin in the shared literature.
Studied across 4 of the same disease areas as Azithromycin in the shared literature.
- RxNorm (U.S. National Library of Medicine) — drug identity
- ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
- Europe PMC — research literature
- ClinicalTrials.gov — clinical trials
- Regulatory event sources are credited in the Regulatory Timeline above.